ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Reviewers Found For Chronobiolgy

June 30, 1989

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

Final stats On FY92 Budget; Success Rate Was 35 Percent

December 4, 1992

Grand Jury Clears Eppley, Shubik

October 24, 1980